These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25811432)

  • 1. A review of the impact of biologics on surgical complications in Crohn's disease.
    Chang MI; Cohen BL; Greenstein AJ
    Inflamm Bowel Dis; 2015 Jun; 21(6):1472-7. PubMed ID: 25811432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy.
    Myrelid P; Marti-Gallostra M; Ashraf S; Sunde ML; Tholin M; Oresland T; Lovegrove RE; Tøttrup A; Kjaer DW; George BD
    Br J Surg; 2014 Apr; 101(5):539-45. PubMed ID: 24615529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery for Crohn's disease and anti-TNF agents: the changing scenario.
    Sorrentino D; Fogel S; Van den Bogaerde J
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):689-700. PubMed ID: 24161133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor necrosis factor and postoperative complications in Crohn's disease: systematic review and meta-analysis.
    Kopylov U; Ben-Horin S; Zmora O; Eliakim R; Katz LH
    Inflamm Bowel Dis; 2012 Dec; 18(12):2404-13. PubMed ID: 22467533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of anti-tumor necrosis factor alpha agents on postoperative anastomotic complications in Crohn's disease: a systematic review.
    El-Hussuna A; Krag A; Olaison G; Bendtsen F; Gluud LL
    Dis Colon Rectum; 2013 Dec; 56(12):1423-33. PubMed ID: 24201398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of post-operative complications in patients with Crohn's disease treated with anti-tumour necrosis factor α agents - a systematic review.
    El-Hussuna A; Theede K; Olaison G
    Dan Med J; 2014 Dec; 61(12):A4975. PubMed ID: 25441731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysis.
    Rosenfeld G; Qian H; Bressler B
    J Crohns Colitis; 2013 Dec; 7(11):868-77. PubMed ID: 23466411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative infliximab use and postoperative complications in Crohn's disease: a systematic review and meta-analysis.
    Yang ZP; Hong L; Wu Q; Wu KC; Fan DM
    Int J Surg; 2014; 12(3):224-30. PubMed ID: 24394691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study.
    Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
    Aliment Pharmacol Ther; 2013 Jan; 37(2):214-24. PubMed ID: 23190161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of postoperative complications following preoperative anti-TNF therapy in patients with Crohn's disease: the need for prospective studies.
    Bamba T; Sohma S; Yamamoto T
    J Crohns Colitis; 2013 Nov; 7(10):e493-4. PubMed ID: 23602136
    [No Abstract]   [Full Text] [Related]  

  • 12. Maneuvering Clinical Pathways for Crohn's Disease.
    Lu TX; Cohen RD
    Curr Gastroenterol Rep; 2019 Apr; 21(5):20. PubMed ID: 31016466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of metastatic Crohn's disease of the skin while on anti-TNF biologics.
    Patel AV; Jones DM; Hill JC; MacDermott RP
    Inflamm Bowel Dis; 2012 Jun; 18(6):1188-90. PubMed ID: 22294342
    [No Abstract]   [Full Text] [Related]  

  • 14. Are the New Biologics Effective in the Management of Postoperative Crohn's Disease?
    Mourad FH; Maalouf RG; Aoun R; Gustavo Kotze P; Hashash JG
    Inflamm Bowel Dis; 2024 Mar; 30(3):459-469. PubMed ID: 36879404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of postoperative Crohn's disease.
    Yang Z; Wu Q; Wu K; Fan D
    Expert Rev Gastroenterol Hepatol; 2014 Sep; 8(7):811-8. PubMed ID: 24809283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-TNF therapy in treatment of luminal Crohn's disease].
    Marko B; Prka L
    Acta Med Croatica; 2013 Apr; 67(2):179-89. PubMed ID: 24471301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.
    Syed A; Cross RK; Flasar MH
    Am J Gastroenterol; 2013 Apr; 108(4):583-93. PubMed ID: 23481144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of post-operative Crohn's disease in 2017: where do we go from here?
    Nguyen V; Kanth R; Gazo J; Sorrentino D
    Expert Rev Gastroenterol Hepatol; 2016 Nov; 10(11):1257-1269. PubMed ID: 27678049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-TNF and Postoperative Complications in Abdominal Crohn's Disease Surgery.
    Yamamoto T; Teixeira FV; Saad-Hossne R; Kotze PG; Danese S
    Curr Drug Targets; 2019; 20(13):1339-1348. PubMed ID: 30947671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological therapy for Crohn's disease in a liver transplant patient.
    Bendezú García RA; Rodríguez Manrique MA; Hernández Martínez A; Lázaro Sáez M; Patrón Román GO; Amat Alcaraz S; Vega Sáenz JL
    J Dig Dis; 2013 Oct; 14(10):564-6. PubMed ID: 23437819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.